This ratio was an independent predictor of shorter recurrence-free survival (Fig S16), suggesting that the impact of TI-CH on outcomes is not merely due to clonal expansions in the blood, and the degree of CHIP-derived tumor infiltration might influence disease outcomes. The gene discussed is STUB1; the disease is neoplasm.